Goldman Sachs
FLXN

Goldman Sachs’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Goldman Sachs’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-8,900
Closed -$180K – 6958
2017
Q2 		$180K Hold
8,900
– – ﹤0.01% 5854
2017
Q1 		$239K Buy
+8,900
New +$182K ﹤0.01% 5614

Goldman Sachs's FLXN Position: Q4 2021 in Review

Goldman Sachs sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 104,244 shares — an estimated $636K sold.

Goldman Sachs first reported a position in FLXN in Q1 2015 and held it in 27 quarters. The position peaked at $9.55M in Q4 2020. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

  • Goldman Sachs reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • Goldman Sachs sold 104,244 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $636K.
  • Goldman Sachs first reported a position in Flexion Therapeutics, Inc. in Q1 2015 and held it in 27 quarters.
  • Goldman Sachs's Flexion Therapeutics, Inc. position peaked at $9.55M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Goldman Sachs's 13F filing for Q4 2021, filed 14 Feb 2022.